Gene · 27306
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Buckwheat Flavonoids Modulate Inflammation in RAW 264.7 Macrophages at Physiologically Relevant Concentrations via the LPS/COX-2 Pathway. | J Agric Food Chem | 2026 | 41824773 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Gut-Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia. | Int J Mol Sci | 2026 | 41751904 | PubTator, text mining | PubMed |
| Reduced Versus Oxidized NAD+ Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes. | FASEB J | 2026 | 41701114 | PubTator, text mining | PubMed |
| The non-catalytic binding of auxin, cytokinin and salicylic acid by tomato Phi class glutathione transferases: insights from computational modelling. | Plant Mol Biol | 2026 | 41632434 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts and its Protective Role against Dementia. | Med Sci Sports Exerc | 2026 | 41582318 | PubTator, text mining | PubMed |
| Decoding adipocyte heterogeneity through single-nucleus transcriptomics unveils subtype-specific adipocytes orchestrate immunosuppressive niches in breast cancer. | J Immunother Cancer | 2026 | 41529909 | PubTator, text mining | PubMed |
| Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. | Clin Transl Med | 2026 | 41527493 | PubTator, text mining | PubMed |
| Comparison of levels of expression of mammalian target of rapamycin (mTOR) and glutathione S-transferases (zeta, sigma, and kappa) in pterygium and normal conjunctival tissues. | J Fr Ophtalmol | 2026 | 41455384 | PubTator, text mining | PubMed |
| Integration of multiple omics reveals key targets and cellular mechanisms for intervention in sarcopenia. | Arch Gerontol Geriatr | 2026 | 41389732 | PubTator, text mining | PubMed |
| ProteoNexus: an integrative database to characterize genetic architecture, estimate mediation effects, and construct and evaluate prediction models of the plasma proteome. | Nucleic Acids Res | 2026 | 41160873 | PubTator, text mining | PubMed |
| Glutathione metabolism and free amino acid profile in Amaranthus palmeri with non-target site-based resistance to sulfonylureas. | Plant Sci | 2026 | 40983232 | PubTator, text mining | PubMed |
| A Review of Bryophytes: Enzymatic and Non-Enzymatic Antioxidants as a Key for Their Pharmacological Potential and Green-Biotechnological Application. | Antioxidants (Basel) | 2025 | 41596075 | PubTator, text mining | PubMed |
| Integrated Metabolomic and Transcriptomic Analyses of the Flavonoid Biosynthetic Pathway in Relation to Color Mutation in Roses. | Biology (Basel) | 2025 | 41154740 | PubTator, text mining | PubMed |
| Fitness Trade-Offs and Potential Metabolic Resistance Mechanisms in Geographically Distinct Strains of Trichogramma dendrolimi: Implications for Imidacloprid Resistance Management. | Insects | 2025 | 41148906 | PubTator, text mining | PubMed |
Discovery and characterization of novel hematopoietic prostaglandin D synthase inhibitors from traditional Chinese medicine: the bioactive potential of dihydroberberine in treatments of Duchenne muscular dystrophy and inflammation-related diseases. | J Enzyme Inhib Med Chem | 2025 | 40960081 | PubTator, text mining | PubMed |
| Optimizing linker rigidity to improve intracellular behavior of PROTACs targeting hematopoietic prostaglandin D synthase. | RSC Med Chem | 2025 | 40937104 | PubTator, text mining | PubMed |
| Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms. | Clin Rev Allergy Immunol | 2025 | 40879847 | PubTator, text mining | PubMed |
| Proteogenomic signature of Alzheimer's disease and related dementia risk in individuals with major depressive disorder. | Nat Ment Health | 2025 | 40823340 | PubTator, text mining | PubMed |
| Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial. | Neuropsychopharmacol Rep | 2025 | 40814256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27306/papers?page=2